The assembly of the classical, polymorphic major histocompatibility complex class I molecules in the endoplasmic reticulum requires the presence of peptide ligands and ~2-microglobulin (~2m). Formation of this trimolecular complex is a prerequisite for e~cient transport to the cell surface, where presented peptides are scanned by T lymphocytes. The function of the other class I molecules is in dispute. The human, nonclassical class I gene, HLA-E, was found to be ubiquitously transcribed, whereas cell surface expression was dif~cult to detect upon transfection. Pulse chase experiments revealed that the HLA-E heavy chain in transfectants, obtained with the murine myeloma cell line P3X63-Ag8.653 (X63), displays a significant reduction in oligosaccharide maturation and intracellular transport compared with HLA-B27 in corresponding transfectants. The accordingly low HLA-E cell surface expression could be significantly enhanced by either reducing the culture temperature or by supplementing the medium with human ~2m, suggesting inefficient binding of endogenous peptides to HLA-E. To analyze whether HLA-E binds peptides and to identify the corresponding ligands, fractions of acid-extracted material from HLA-E/X63 transfectants were separated by reverse phase HPLC and were tested for their ability to enhance HLA-E cell surface expression. Two fractions specifically increased the HLA class I expression on the HLA-E transfectant clone.
Summary
The assembly of the classical, polymorphic major histocompatibility complex class I molecules in the endoplasmic reticulum requires the presence of peptide ligands and ~2-microglobulin (~2m). Formation of this trimolecular complex is a prerequisite for e~cient transport to the cell surface, where presented peptides are scanned by T lymphocytes. The function of the other class I molecules is in dispute. The human, nonclassical class I gene, HLA-E, was found to be ubiquitously transcribed, whereas cell surface expression was dif~cult to detect upon transfection. Pulse chase experiments revealed that the HLA-E heavy chain in transfectants, obtained with the murine myeloma cell line P3X63-Ag8.653 (X63), displays a significant reduction in oligosaccharide maturation and intracellular transport compared with HLA-B27 in corresponding transfectants. The accordingly low HLA-E cell surface expression could be significantly enhanced by either reducing the culture temperature or by supplementing the medium with human ~2m, suggesting inefficient binding of endogenous peptides to HLA-E. To analyze whether HLA-E binds peptides and to identify the corresponding ligands, fractions of acid-extracted material from HLA-E/X63 transfectants were separated by reverse phase HPLC and were tested for their ability to enhance HLA-E cell surface expression. Two fractions specifically increased the HLA class I expression on the HLA-E transfectant clone.
A variety of the molecules involved in vertebrate immune recognition are encoded by the MHC. In humans these include three highly polymorphic dass I transplantation antigens (HLA-A, -B, -C). These so-called dassical class I MHC molecules are composed of a MHC-encoded transmembrane heavy chain (Mr ~44,000; 44K) noncovalently associated with ~2-microglobulin (Bzm). 1 They present antigens to CTL, due to their capacity to bind peptides from intracellularly degraded proteins, and expose them on the cell surface (1, 2) . Moreover, intracellular transport and cell surface expression of classical class I molecules are controlled by the efticient assembly of this trimolecular complex and depend on the availability of high affinity peptides within the endoplasmic reticulum (3) (4) (5) (6) (7) (8) (9) . Whether or not the less polymorphic nonclassical class I loci (HLA-E [10, 11] , -F [12] , and -G [13, 14] ) also function in antigen presentation in humans is unknown.
Like the classical HLA class I genes, HLA-E, localized be- tween the HLA-C and the HLA-A loci, is highly transcribed in most tissues (10, 11, 15 ; M. Ulbrecht, manuscript submitred for publication). Conflicting results have been obtained concerning the cell surface expression of the HLA-E-encoded class I heavy chain. Upon transfection of a HLA-E 6.2-kb HindlII subclone of cosmid B1.1 (E'0102) into an HLA dass I-negative mutant B-LCL, only an intracellular 41 K heavy chain could be coprecipitated with human ~2m (hu~zm) (10, 16) . In constrast, the transfer of a 16-kb EcoRI subclone derived from cosmid RS5 was reported to result in a detectable cell surface expression when transfected into mouse L cells, which also express hu~2m (17) . We recently found low cell surface expression of HLA-E antigen in the mouse myeloma cell line P3X63-AgS.653 (X63) transfected with cosmid cd3.14 (E*0105) and hu~/2m. The discrepancy between the size of the metabolically labeled HLA-E heavy chain (Mr 41 K) and the size of the iodinated surface HLA-E chain (Mr 42 K) precipitated from these cells suggests a defect in N-linked glycan maturation. Here we present evidence that the lack of productive cell surface expression of HLA-E is the result of a low stability of the HLA-E molecule during transport and on the cell surface, which may be due to its defective binding of available endogenous peptides. Antibodies. Supernatants of hybridomas producing mAbs specific for human class I, B9.12.1 (IgG2a [18] ); human B2m, BBM.1 (IgG2b; American Type Culture Collection, Rockville, MD); purified mAbs specific for human CD4, M-T151 (IgG2a), and M-T242 (IgG2b); and human class I heavy chain, A1.4 (IgG2b [19] ; United Biomedical Inc., Hauppauge, NY) were used for immunofluorescence and immunoprecipitation. 
Materials and Methods

Preparation of Radiotabeled Proteins. For metabolic labeling, cells
(1-3 x 106/ml) were preincubated for 1.5 h in methionine-free MEM supplemented with 10% dialyzed FCS (all from Gibco Laboratories) at 37~ Cells were then pulse labeled with 20 #Ci/ml [3SS]methionine (>1,000 Ci/mmol; Amersham Corp., Arlington Heights, IL) for 10 min at 37~ and chased in the presence of a 200-400-fold molar excess of cold methionine at 37~ or where indicated at 26~ At the time points indicated aliquots were removed and lysed.
Iodination of cell surface molecules was carried out using the lactoperoxidase-glucose oxidase method (20) . In brief, 107 cells cultured at either 37 or 26~ for 24 h were washed twice with PBS and labeled in I ml of PBS with 5 U lactoperoxidase (L-0515; Sigma Chemical Co.), 6 U glucose oxidase type V (Sigma Chemical Co.), and 1 mCi of carrier-free NanSI (17.4 Ci/mg; DuPont Co., Wilmington, DE) in the presence of 0.01 mM KI and 5 mM D-glucose for 20 min at room temperature. Cells were washed five times in PBS/10% FCS and lysed.
ImraunoFrecit~itation and SDS-PAGE. [3sS]-Methionine metabol-
ically labded calls were lysed at 4~ for 30 rain in 0.6 ml lysis buffer (1% [wt/vol] NP-40, 2 mM benzamidine HC1, 2 mM PMSF, 2% [vol/vol] aprotinin in PBS). After sedimentation of nuclei and debris at 15,000 g for 15 rain at 4~ lysates were supplemented with 50 #1 of FCS and precleared at 4~ one to three times for 12 h with 100 #1 horse serum-saturated Sepharose 6B (Pharmacia Fine Chemicals, Piscataway, NJ), one to two times for 2 h with 50 #1 of protein A-Sepharose Cb4B (Sigma Chemical Co.), and once for 1 h with 20 /zl of isotype control mAb(M-T151 or M-T242)-protein A-Sepharose. After a last preclearing step with 20 #1 of protein A-Sepharose for 1 h, lysates were incubated for 1 h at 4~ with 20 #1 of either A1.4-or B9.12.1-protein A-Sepharose. Immunoadsorbents were washed six times in PBS containing 0.2% (wt/vol) NP-40, resuspended in 50 #1 of SDS sample buffer (4.2% SDS, 0.1% 2-ME, 18% glycerol), boiled for 3 min, and analysed by SDS-PAGE on 9, 10, or 12% gels. The gels were treated with Amplify (Amersham Corp.), dried, and fluorographed at -85~ For 12SI-labeled proteins a modification of this protocol was adopted. After preclearing at 4~ for the first 15 h with 100/~1 of horse serum-saturated Sepharose and then for 2 h with 25/~1 of protein A-Sepharose, lysates were sequentially immunoprecipitated (1 h 
Endo H Treatment of Radiolabeled Proteins. After washing with
PBS containing 0.2% (wt/vol) NP-40, immunoadsorbents were split into two equal aliquots, resuspended in 26/~1 of sodium phosphate buffer (50 mM, pH 5.5) supplemented with 0.1 M 2-ME and 0.02% SDS, boiled for 1 min, and then cooled on ice. 1/~1 of 200 mM PMSF and 8 #1 ofendo H (1 mU//~l; Boehringer Mannhelm Biochemicals) were added (control samples receiving 8/~1PBS), and digestion was performed at 37~ for 15 h under gentle agitation. Samples were analyzed as described by 10 or 12% SDS-PAGE.
Acid Extraction of Peptides and HPI_s Separation. 3 x 10 s
human B2m/HLA-E-transfected X63 cells kept at 37~ and washed twice with PBS were resuspended in 0.1% (vol/vol) TFA. Extraction was performed as described (21) . Lyophilized material was resuspended in 0.1% TFA and subjected to a Sephadex G-25 gel filtration column (Pharmacia Fine Chemicals). Material of M, <10 K was collected and dried by vacuum centrifugation. The extract was dissolved in 0.1% TFA and separated by HPLC (LKB Instruments) on a reverse phase column, Hibar LiChrospher (Merck), using (a) 0.1% TFA/H20, and (b) 0.1% TFA/acetonitrile as a solvent system. A linear gradient from 0 to 70% (vol/vol) of b in a was applied over a period of 60 min at room temperature. The flow rate was adjusted to 1 ml/min. The effluent was monitored at 206 nm. Fractions of 1 rain were collected and dried by vacuum centrifugation.
Results
Impaired Intracellular Transport of HLA-E Molecules. Posttranslational modifications and intracellular transport of HLA-E and HLA-B27 heavy chains were investigated by pulse chase experiments (Fig. 1) . Comparing X63 transfectants, expressing only hu~2m, HLA-E and hu~zm, or HLA-B27 and hu/32m, revealed that the HLA-B27 molecules showed extensive glycan modification during the chase period of 90 min (Fig. 1 a) and expressed predominantly mature (endo H-resistant) glycans at 120 rain (Fig. 1 b) . In contrast, HLA-E molecules did not increase in size (Fig. 1 a) and remained endo H sensitive (Fig. 1 b) . In biosynthetically labeled cells, both HLA-E and HLA-B27 heavy chains were precipitated at least partially complexed with B2m (see Fig. 5 ), irrespective of the mAb used (B9.12.1 [18] or A1.4, which also recognizes denatured class I heavy chains [19] ).
Enhancement of HLA-E Surface Expression at Low Temperature.
A defect in carbohydrate side chain processing and intracellular trafficking of dassical MHC class I molecules, which has been observed in the absence of peptide ligands, could be compensated for by a reduction in temperature (4, 22) . Culturing the X63 transfectants at 26~ resulted in a threeto eightfold increase of human class I-specific cell surface immunofluorescence of the HLA-E transfectant, whereas no effect was observed on the HLA-B27 expression (Fig. 2) . Maximum expression was reached after a 4-h culture period and persisted up to 48 h. Labeling of cell surface class I molecules and immunoprecipitation confirmed the increase of HLA-E molecules on the cell surface (Fig. 3) . Whereas in metabolically labeled cells a M, 41 
Enhancement of HLA-E Surface Expression by Exogenous hu3em.
Sequential immunoprecipitation using mAb B9.12.1 followed by A1.4 indicates that the majority of HLA-E and a substantial fraction of HLA-B27 are present on the cell surface of the X63 transfectants as free class I heavy chains, not complexed with/32m (Fig. 3 b) . Some HLA-E molecules are complexed with 32m on the cell surface when immunoprecipitated with anti-/32m (BBM.1; Fig. 3 b) . Since immunoprecipitation of metabolically and cell surface-labeled cells was performed under the same conditions with concentrated cell lysates, the great reduction of B2m-associated HLA-E polypeptide in cell surface-labeled lysates should not be due to a subsequent enhanced dissociation of the iodinated HLA-E molecule (23) . Figure 2. Enhancement of cell surface expression of the HLA-E class I molecules at low temperature or by excess huB2m in the medium. X63 transfectant clones expressing either hu~zm alone, HLA-E and hu~2m, or HLA-B27 and huB2m were cultured either at 37~ in absence or presence of huBzm, or at 26~ for 12 h and subsequently stained with mAbs against HLA class I (B9.12.1) and huB2m (BBM.1). Specific indirect fluorescence profiles were compared to second antibody alone ( ...... ). The same staining profiles were obtained using the mAb A1.4.
Exogenous 32m has been shown to stabilize free heavy chains on the cell surface (24) . Incubation of the X63 transfectants for 12 h at 37~ in the presence of exogenous huB2m led to the same increase in HLA-E cell surface expression as observed after 12 h at 26~ (Fig. 2) . No increase was detected after a 1-h incubation with hu32m. An increased level of huB2m at the cell surface of the HLA-E transfectant was only observed when hu32m was in the medium. Again, neither treatment affected HLA-B27 cell surface expression. The association of exogenous hu~2m with mouse cells has been described to be rapid (24) , reaching saturation after 15 min and reflecting the presence of a large pool of free class I heavy chains on the mouse cells tested. The prolonged time required for enhanced HLA-E expression suggests that free HLA-E is not present on the cell surface in a conformation undetectable by the reagents used, but that HLA-E polypeptides reaching the cell surface are continuously stabilized. This is confirmed by the lack of any increase of HLA-E cell surface expression in the presence of brefeldin A (BFA), which inhibits further intracellular transport (Fig.  4) (4, 25) . In contrast, purified mouse 132m did not enhance HLA-E cell surface expression (data not shown).
Low Temperature Stabilizes Mature HLA-E Molecules.
To correlate the enhancement of HLA-E surface expression at low temperature with the underlying processes of intracellular transport, transfectants were pulse labded at 37~ and equal aliquots chased at either 37 or 26~ Low temperature reduces the turnover both of immature M, 41 K HLA-E heavy chains and HLA-E molecules of M, 42 K with mature glycans, though the effect on the processed form predominates (Fig. 5) . The mature Mr 42 K form of HLA-E is abundantly detectable when chased at 26~ whereas only trace amounts precipitate after a 4-h chase at 37~ This is not a result of an increase in processing rate, since equal amounts of immature HLA-E c~ chains are precipitated after a 4-h chase at both temperatures. In contrast, reduction of the chase temperature had little influence on the turnover and the oligosaccharide maturation of the HLA-B27 heavy chain. That the residual immature form can be detected after 4 h at 37~ whereas only a mature product is seen in cells chased at 26~ might indicate that HLA-B27-1inked glycan modification was accelerated at 26~ At either chase temperature the HLA-E molecules failed to show complete oligosaccharide maturation even after 8 h, implying a reduced rate of intracellular transport. The experiments suggest that after reaching the cell surface at 37~ the mature form may dissociate from Bzm and be rapidly degraded. Since the mAb A1.4 also recognizes denatured HLA class I heavy chains, the turnover of the HLA-E polypeptide at 37~ should not be due to irreversible denaturation. Incubation at 26~ or the presence of exogenous hu~2m stabilizes the conformation of HLA-E and thus inhibits its degradation.
Enhancement of HLA-E Cell Su~ace Expression by Fluted Pep tide Material.
The observation that cell surface expression of the HLA-E antigen was only detected upon transfection into X63 cells might indicate that these cells contain a low [ ] 2soc
X 6 3 huff2rn, E X 6 3 hu~62rn, B27 Figure 4 . BFA inhibits enhancement of cell surface expression of the HLA-E class I molecules at low temperature or by excess hu/Szm in the medium. Aliquots of hu/3zm +, hu/3~n/HLA-E +, hu/3zm/HLA-B27 + X63 transfectant clones were preincubated for 30 min at 370C in the presence of BFA. Cells were then kept for 5 h either at 370C, with or without addition of 12 t~g/ml of purified hu/$2m, or at 260C. Cells were then stained with mAb AL4 by indirect immunolluorescence. Fluorescence intensities are indicated as mean channels. amount of sdf-peptides capable of binding to this dass I molecule, or that they are permissive to the cell surface transport of empty, otherwise retained, class I molecules. To analyze whether HLA-E has the ability to bind peptides and to identify the corresponding ligands, acid extracts of the X63/hu/32m, HLA-E transfectant were prepared as described, and peptides of Mr <10 K were further fractionated by reverse phase HPLC (21, 26). We reasoned that the small amount of 132m-associated mature HLA-E antigen on the cell surface might be peptide ligand associated. Individual peptide fractions were tested for the enhancement of HLA-E or HLA-B27 cell surface expression (Fig. 6 ). Two fractions (23 and 24) significantly enhanced the HLA class I expression on the HLA-E transfectant clone. None of the fractions had an effect on the HLA-B27 transfectant (data not shown). Adopting the same elution protocol, purified huB2m eluted from the reverse phase HPLC column in fraction 38.
Discussion
These findings suggest that the impaired expression of the HLA-E antigen may be the result of insufficient binding of peptide ligands (3, 7) or of complexing longer peptides, giving rise to unstable molecules (27) . Further experiments are needed to determine whether the extracted ligands were originally complexed with HLA-E. Sequence analysis of the purified peptides and identification of the self-protein will reveal whether the aberrant expression of the HLA-E molecule results from an insufficient pool of self-peptides capable of binding to HLA-E, or whether the structure of its binding cleft only accommodates peptides with a rare composition. Protein sequence comparison does not indicate the presence of substitutions at positions known to be crucial for ligand binding (28) .
In addition, HLA-E antigen expression may be affected by a reduced translation efficiency since the amount of HLA-E mRNA did not correlate with the HLA-E cell surface staining in transfectant clones. The clones used in the experiments presented here contained similar amounts of steady-state hu/~2m and HLA class I mRNA, comparable with human tissues (M. Ulbrecht, manuscript submitted for publication). Regardless of the reagent used for immunoprecipitation of pulse-labeled class I, the amount of HLA-E polypeptide was drastically reduced compared with the HLA-B27 immunoprecipitates. The possibility of a rapid conversion of HLA-E into a non-hu132m-associated form that is not recognized by A1.4 cannot formally be excluded.
It is unlikely that the poor cell surface expression of the HLA-E molecule is only due to its expression in a mouse cell line. Class I antigen cell surface expression is easily detected upon transfection of HLA-A, -B, and -C genes (29, 30) and no species-specific restriction in peptide binding and class I assembly has been described so far, although variability in MHC-encoded transporter or proteasome genes might affect the endoplasmic peptide spectrum (7, 31) . Indeed, defective cell surface expression of the HLA-E antigen was also observed upon transfection into human B-LCL 721.221 (16) cells. HLA-E might be representative for a class of relative invariant class I antigens found in all species studied so far that share weak cell surface representation (16, 32, 33) .
Our results might suggest that the structure of HLA-E has evolved such that this class I antigen lost its function in presenting antigenic peptides to the immune system. This must not necessarily be true, since HLA-E, in its biochemical properties, behaves very similarly to H-2L a, which serves as a restriction element for several virus-specific cytotoxic T cell responses in H-2 d mouse strains (34, 35) . Moreover, the homologue of a nonpolymorphic HLA molecule, HLA-G, functions as major restriction element in a New World primate species (36) .
A specific physiological role for nonclassical MHC class I molecules is only emerging now. In the mouse, such molecules can present synthetic peptides to T cells, and it has been postulated that they display a greater specialization of peptide binding than the classical MHC molecules (37) (38) (39) (40) . Several reports have suggested that TL region class I gene products might be involved in antigen presentation to y/8 receptor-bearing T cells (38, 41) . The influence of heat-shock proteins on Qa-1 cell surface expression (42) , and the finding that several 3'//5 T cell lines recognize heat-shock proteins (43) , have led to the hypothesis that the TL molecules and other nonclassical MHC class I molecules might, as a primary line of defense, present peptides derived from an endogenous stress-response protein to "y/8 T cells (42) . In addition, since they are not saturated with endogenous peptides, they might preferentially bind environmental antigens that can be recognized by the immune system. The observed stabilization of HLA-E class I antigens at reduced temperature might be of physiological significance in the skin, where the temperature is lower than elsewhere in the body.
It is also conceivable that HLA-E serves a more "ancient" function intracellularly as a "modulator" of endoplasmic peptide loading. This may be related to the function of heatshock proteins (hsp70), in which the hypothetical structure of the peptide binding domain is similar to the MHC an-tigen binding site (44, 45) . Since HLA-E is retained and accumulates in the class I "peptide-loading" compartment, the endoplasmic reticulum, it might influence the spectrum of peptides presented by classical class I molecules through low a~nity binding and easy release of peptides, thus modulating the concentration of free peptides available. Finally, HLA-E might be involved in the postulated process of trimming preprocessed peptides to the biologically active length of eight to nine amino acids.
